BCL-xL/BCL2L1 is a critical anti-apoptotic protein that promotes the survival of differentiating pancreatic cells from human pluripotent stem cells LSW Loo, AAP Soetedjo, HH Lau, NHJ Ng, S Ghosh, L Nguyen, ... Cell death & disease 11 (5), 378, 2020 | 39 | 2020 |
Tissue engineering and 3D printing of bioartificial pancreas for regenerative medicine in diabetes AAP Soetedjo, JM Lee, HH Lau, GL Goh, J An, Y Koh, WY Yeong, ... Trends in Endocrinology & Metabolism 32 (8), 609-622, 2021 | 28 | 2021 |
Tools for bioimaging pancreatic β cells in diabetes NY Kang, AAP Soetedjo, NS Amirruddin, YT Chang, O Eriksson, AKK Teo Trends in Molecular Medicine 25 (8), 708-722, 2019 | 28 | 2019 |
Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency EEK Tan, RA Hopkins, CK Lim, SS Jamuar, C Ong, KC Thoon, MJA Koh, ... The Journal of Clinical Investigation 130 (11), 5817-5832, 2020 | 20 | 2020 |
Dynamic proteome profiling of human pluripotent stem cell-derived pancreatic progenitors LSW Loo, H Vethe, AAP Soetedjo, JA Paulo, J Jasmen, N Jackson, ... Stem Cells 38 (4), 542-555, 2020 | 7 | 2020 |
A new perspective of probe development for imaging pancreatic beta cell in vivo CWY Neo, LM Ciaramicoli, AAP Soetedjo, AKK Teo, NY Kang Seminars in Cell & Developmental Biology 103, 3-13, 2020 | 6 | 2020 |
BCL-xL/BCL2L1 Is a Critical Anti-Apoptotic Protein that Suppresses BAK to Promote Pancreatic Specification from Human Pluripotent Stem Cells LSW Loo, A Teo, S Ghosh, AAP Soetedjo, L Nguyen, VG Krishnan, ... DIABETES 68, 2019 | | 2019 |
326-LB: BCL-xL/BCL2L1 Is a Critical Anti-Apoptotic Protein that Suppresses BAK to Promote Pancreatic Specification from Human Pluripotent Stem Cells L SAI WENG LOO, A TEO, S GHOSH, A ALVIN PURNOMO SOETEDJO, ... Diabetes 68 (Supplement_1), 2019 | | 2019 |